Medical risk-assessment tools maker Semler Scientific raises $10 million, meeting a lowered projection for its initial public offering.
Oregon-based Semler Scientific (NSDQ:SMLR) closed its initial public offering with just over $10 million raised.
GC Aesthetics says it raised $60 million from a trio of healthcare investors.
GC Aesthetics brought $60 million from 3 healthcare investment groups it plans to use to expand its breast implant business.
Dublin-based GC Aesthetics is the umbrella company for 2 different brands, Nagor and Eurosilicone.The funding round was led by a $40 million contribution from OrbiMed, with existing backers Montreux Equity Partners and Oyster Capital contributing the rest.
Volcano agrees that St. Jude Medical isn't infringing a pair of its fractional flow reserve patents after a court ruling doesn't go its way, but vows to appeal.
Mobile health company Glooko launches a population tracker connected to its smartphone blood glucose monitoring system, giving healthcare providers new tools to identify at-risk patients and bring them in for intervention prior to an emergency situation.
California diabetes management company Glooko Inc. this month unveiled its new Population Tracker, offering health systems patient monitoring that aims to keep track of at-risk patients and reduce hospitalizations.
eNeura Therapeutics, which won an FDA nod for its transcranial magnetic stimulation device for migraine last year, adds another $1.6 million to its coffers.
eNeura Therapeutics added to the $2.2 million it raised earlier this year with another $1.6 million deposit, part of a hoped-for $2 million funding round, according to a regulatory filing.
Sunnyvale, Calif.-based eNeura makes a transcranial magnetic stimulation device designed to treat migraine headaches.
The Emergo Group Blog provides short updates on quality and regulatory topics that may be of interest to QA/RA professionals in the medical device and IVD industry. No fluff, just straight to the point. We hope you'll enjoy the content.
By Stewart Eisenhart, Emergo Group
Arrhythmia Research Technologies and Blue Belt Technologies ink a supply deal for components used in Blue Belt's Stride knee implant.
Arrhythmia Research Technology (NYSE:HRT) subsidiary Micron Products said it inked a deal to supply components for Blue Belt Technologies' Stride unicondylar knee implant system.
